Skip to content

Multimodal Music Therapy for Children With Anxiety Disorders

A Randomized Controlled Trial of Multimodal Music Therapy for Children With Anxiety Disorders

Status
Completed
Phases
Phase 3
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01062646
Enrollment
36
Registered
2010-02-04
Start date
2006-05-31
Completion date
2009-09-30
Last updated
2010-02-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Anxiety

Keywords

music therapy, multimodal psychotherapy, children, anxiety disorders, pediatric anxiety

Brief summary

Multimodal music therapy (MT) for children ages 8 to 12 years with anxiety disorders is compared to community treatment as usual (TAU). 36 children were randomized either to MT or to TAU. Primary outcome is presence of an anxiety disorder at the end of treatment. Secondary outcomes are self- and parent-/teacher reported anxiety, co-morbid psychological symptoms, and quality of life. Stability of outcome is assessed six months after the end of treatment.

Detailed description

Patients were enrolled in a community clinic and in an outpatient clinic for child and adolescent psychiatry/psychotherapy. Inclusion criteria: diagnosis of an anxiety disorder (separation anxiety disorder, general anxiety disorder, social phobia, specific phobia, or other anxiety disorder); age 8-12; no medication or stable medication during treatment; IQ\>80; informed consent of caregivers and informed assent of patients. Outcome measures. Kiddie-SADS; STAIC-C, SPAIC, CDI; SDQ teacher report; CBCL 4-18; ILK quality of life inventory. Assessment time points: pre-intervention; post-intervention; 6-months follow-up.

Interventions

BEHAVIORALCommunity treatment as usual

Sponsors

University of Ulm
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
8 Years to 12 Years
Healthy volunteers
No

Inclusion criteria

* age 8-12 years * diagnosis of an anxiety disorder * IQ\>80 * informed consent and assent

Exclusion criteria

* anxiety disorder is not primary focus of treatment

Design outcomes

Primary

MeasureTime frame
Diagnosis of an anxiety disorder (DSM IV)

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026